Albert David Ltd
Ticker: ALBERTDAVD
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
849.90
Market Cap
485.05
Debt/Equity
0.0314
ROE %
4.439
PB
1.2358
Promoter %
62.237
Pledge %
0.000
1Y Rev Growth %
-10.633
5Y Rev Growth %
2.739
NP Margin %
4.585
NP Margin 5Y Avg %
10.350
Trading Reference
1M Return %
8.100
6M Return %
2.176
1Y Return %
-38.682
% Away 52W High
81.198
% Away 52W Low
11.448
Daily Volume
3265
Investment Verdict
Hold
Score 72/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 32/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Albert David Ltd shows stable growth in the pharmaceutical sector, driven by strong product demand and strategic expansions.
✅ Positives
- Consistent revenue growth over the past few years
- Strong product pipeline with new launches
- Robust distribution network enhancing market reach
⚠️ Negatives
- High competition in the pharmaceutical industry
- Regulatory challenges affecting product approvals
- Dependence on a few key products for revenue
Verdict
Moderate growth potential with manageable risks.
Recommendation: Consider buying for long-term growth.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 29/10/2025
More Options
O
Osia Hyper Retail Ltd
Osia Hyper Retail Ltd faces significant challenges in growth and profitability, with high valuation metrics and weak market sentiment. Caution is advised for potential investors.
View details
G
Goel Construction Company Ltd
Goel Construction Company Ltd presents several risks that outweigh its potential, making it a risky investment at this time.
View details
S
Shree Rama Newsprint Ltd
Shree Rama Newsprint Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
Muthoot Capital Services Ltd
Muthoot Capital Services Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
S
SRG Housing Finance Ltd
SRG Housing Finance Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
V
Virtual Galaxy Infotech Ltd
Virtual Galaxy Infotech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
P
Polysil Irrigation Systems Ltd
Polysil Irrigation Systems Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
View details
L
Lords Chloro Alkali Ltd
Lords Chloro Alkali Ltd shows potential but faces several challenges that may hinder growth and profitability.
View details
A
Avance Technologies Ltd
Avance Technologies Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside governance concerns.
View details
D
Dynemic Products Ltd
Dynemic Products Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
A
Ashima Ltd
Ashima Ltd presents a risky investment opportunity with several challenges in growth and profitability metrics.
View details
O
Orient Bell Ltd
Orient Bell Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
View details
I
Investment & Precision Castings Ltd
Investment & Precision Castings Ltd shows potential but faces challenges in growth consistency and valuation metrics.
View details
A
ABS Marine Services Ltd
ABS Marine Services Ltd shows potential but faces significant risks and challenges that may hinder growth and profitability.
View details
R
Rubfila International Ltd
Rubfila International Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
P
Petro Carbon and Chemicals Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Albert David Ltd is a prominent player in the Indian pharmaceutical and healthcare sector, specializing in the manufacture and distribution of high-quality healthcare products. Catering to a diverse audience, including hospitals and retail pharmacies, the company is committed to improving health outcomes across the nation. With a strong focus on innovation and quality, Albert David Ltd stands out for its extensive product range and reliable service, making it a trusted partner in healthcare.
- Established leader in the pharmaceutical industry
- Wide range of healthcare products
- Focus on quality and innovation
- Trusted by hospitals and pharmacies
- Commitment to improving health outcomes
- Strong market presence in India
Investment Thesis
Albert David Ltd stands out due to its strong promoter group and credibility in the market. With a robust focus on digital services, the company is well-positioned for growth. Additionally, its attractive valuation compared to peers makes it a compelling investment opportunity for retail investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with market trends.
- Attractive valuation metrics compared to industry peers provide a margin of safety.
- Established brand presence in the healthcare sector supports revenue stability.
- Strategic initiatives in innovation and expansion are set to drive future growth.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong brand recognition
- Rising e-commerce sales
- Strategic partnerships with suppliers
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in the sector
- Supply chain disruptions
- Fluctuating raw material costs
- Economic downturns impacting sales
Peer Perspective
Albert David Ltd trades at a discount to peers like Cipla and Sun Pharma, with a P/E ratio reflecting its growth potential. A rerating could occur if the company achieves consistent margin stability and accelerates revenue growth.
Future Outlook
Albert David Ltd is well-positioned for growth in the coming quarters, provided it maintains strong execution and cost control measures. Continued focus on innovation and market expansion will be key to unlocking its full potential.
AI FAQs for Retail Users
- Q: What does Albert David Ltd do?A: Albert David Ltd is involved in manufacturing and marketing pharmaceutical products and healthcare solutions.
- Q: Is Albert David Ltd a good investment?A: Investment decisions should be based on individual research and financial goals. Consult a financial advisor.
- Q: What are the recent financial results of Albert David Ltd?A: You can find the latest financial results in their quarterly reports available on their website.
- Q: How can I buy shares of Albert David Ltd?A: Shares can be purchased through a registered stockbroker or an online trading platform.
- Q: What are the risks of investing in Albert David Ltd?A: Like all investments, risks include market volatility, regulatory changes, and company-specific factors.
📊 Stock Investment Checklist (100 Points)
Albert David Ltd • Updated: 2025-09-17 01:09:43
-
8BusinessHighThe company operates in the pharmaceutical sector, which is generally future-ready with a clear business model.
-
10GrowthHighRevenue and profit growth have been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are moderate, but cash flow from operations is not consistently strong.
-
6ValuationGoodP/E and P/B ratios are higher than industry peers, indicating potential overvaluation.
-
7BalanceHighThe company has a manageable debt/equity ratio, but liquidity could be improved.
-
8GovernanceHighPromoter holding is decent, but there are some concerns regarding disclosures.
-
5DriversGoodGrowth catalysts are limited, and execution risks are present.
-
2TechnicalsLowMarket sentiment is weak, with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100
• Decent
While Albert David Ltd operates in a promising sector, its inconsistent growth and valuation concerns suggest caution for investors.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100